Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04870255 · ClinicalTrials.gov registry record · NA
Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
A NA study of Depressive Disorder, Major and Borderline Personality Disorder, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04870255 is a NA study of Depressive Disorder, Major and Borderline Personality Disorder that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 45 participants, below the 241-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04870255, a NA study of Depressive Disorder, Major and Borderline Personality Disorder, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the antidepressant effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), in individuals with borderline personality disorder (BPD) or trait and comorbid mood depressive disorder (MDD) or bipolar II disorder in a current mood depressive episode (MDE).
Conditions Studied
Interventions
- DEVICE Sham Stimulation
- DEVICE Left Dorsolateral Prefrontal Cortex (L-DLPFC)
- DEVICE Dorsomedial Prefrontal Cortex (DMPFC)
Study Locations (1)
California
- Stanford Hospital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04870255
The ClinicalTrials.gov registry entry for NCT04870255 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (81% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depressive Disorder, Major appearing as the primary indexed condition, and to 3 interventions - of which Sham Stimulation is the first listed.
NCT04870255 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04870255 about?
NCT04870255 is a clinical study titled "Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS". This study evaluates the antidepressant effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), in individuals with borderline personality disorder (BPD) or trait and comorbid mood depressive disorder (MDD) or bipolar II disorde...
What is the current status of trial NCT04870255?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2021-07-20. Estimated completion is 2026-12.
What conditions does trial NCT04870255 study?
This clinical trial studies the following conditions: Depressive Disorder, Major, Borderline Personality Disorder.
What interventions are being tested in trial NCT04870255?
The interventions under investigation include: Sham Stimulation (DEVICE), Left Dorsolateral Prefrontal Cortex (L-DLPFC) (DEVICE), Dorsomedial Prefrontal Cortex (DMPFC) (DEVICE).
Who is sponsoring clinical trial NCT04870255?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04870255 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Disorder, Major
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
RECRUITING · NA
-
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
RECRUITING · NA
-
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
RECRUITING · NA
-
Biomarkers of Depression and Treatment Response
RECRUITING · NA
-
In-person vs. Remote Wellness Support
COMPLETED · NA
Explore more on PlainTrial
Depressive Disorder, Major
All registered trials for this condition
Borderline Personality Disorder
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.